Finance entity
markets is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Evolus, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.4 for that window.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Evolus, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.4 for that window. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline. We currently track 1 Finance story that mention Evolysse, all published on March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 105 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Evolysse. Shared-story counts are live from our verified record — not editorial picks.
Insider Sale
CMO Rui Avelar sells 29,996 shares of EOLS stock.
Revenue Targets Raised
Management increases 2028 revenue goals citing market stabilization.
SEC Filing Update
Company files notice regarding changes or departures in director/officer roles.
Q4 Earnings Beat
Evolus reports record results and triggers a significant stock rally.
Evolus Chief Medical Officer Rui Avelar sold 29,996 shares of EOLS stock on March 19, 2026, following a period of significant price appreciation. The transaction occurs as the aesthetics company raises its long-term revenue targets and reports stabilizing trends in the neurotoxin market.
Source: dailypolitical.com · themarketsdaily.com
Evolysse is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
